Thursday, July 27, 2023 9:37:06 AM
July 26 2023
https://ih.advfn.com/stock-market/NYSE/lightning-emotors-ZEV/stock-news/91651025/lightning-emotors-to-report-second-quarter-2023-ea
Lightning eMotors, Inc. (NYSE: ZEV), a leading provider of zero emission medium-duty commercial vehicles and electric vehicle technology for fleets, today announced that the Company will release its second quarter 2023 results after the market closes Monday, August 14, 2023, followed by a conference call to be held at 4:30 p.m. Eastern Time the same day.
Interested investors and other parties can listen to a webcast of the live conference call by visiting the Investor Relations section of the Company's website at ir.lightningemotors.com.
The conference call can be accessed live over the phone by dialing 877-407-6910 (domestic) or +1-201-689-8731 (international).
About Lightning eMotors
Lightning eMotors (NYSE: ZEV) has been providing specialized and sustainable fleet solutions since 2009, deploying complete zero-emission-vehicle solutions for commercial fleets since 2018 – including cargo and passenger vans, ambulances, shuttle buses, Type A school buses, work trucks, city buses, and motor coaches. The Lightning eMotors team designs, engineers, customizes, and manufactures zero-emission vehicles to support the wide array of fleet customer needs with a full suite of control software, telematics, analytics, and charging solutions to simplify the buying and ownership experience and maximize uptime and energy efficiency. To learn more, visit our website at https://lightningemotors.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230726198452/en/
Brian Smith
investorrelations@lightningemotors.com
Recent ZEVY News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2024 09:02:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 09:05:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2023 10:14:29 PM
- Firm Announces Acceptances into IRS Commercial Clean Vehicle Credit Program. • AllPennyStocks.com • 10/05/2023 03:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM